![Jeremy Bender](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeremy Bender
Directeur/Membre du Conseil chez
MEREO BIOPHARMA GROUP PLC
Fortune : 228 417 $ au 31/05/2026
Profil
Jeremy Bender is currently Chief Executive Officer at DOT Therapeutics-2, Inc., Independent Director at Mereo BioPharma Group Plc since 2020, and Independent Director at Aura Biosciences, Inc. starting in 2026.
Formerly, Dr. Bender was President, CEO & Non-Independent Director at Day One Biopharmaceuticals, Inc. from 2020 to 2026, Director at Fusion Pharmaceuticals, Inc. from 2023 to 2024, Vice President-Corporate Development at Gilead Sciences, Inc. from 2018 to 2020, Vice President-Corporate Development at Allos Therapeutics, Inc. from 2006 to 2012, Chief Business Officer at Sutro Biopharma, Inc. from 2012 to 2015, Project Leader at The Boston Consulting Group, Inc., and Chief Operating Officer at Tizona Therapeutics, Inc. from 2015 to 2018.
Education includes undergraduate studies at Stanford University, a doctorate from The University of Colorado, and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,05% | 07/07/2026 | 30 000 ( 0,05% ) | 224 100 $ | 31/05/2026 |
| 26/03/2026 | 62 750 ( 0,01% ) | 4 317 $ | 31/05/2026 |
Postes actifs de Jeremy Bender
| Sociétés | Poste | Début |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Directeur/Membre du Conseil | 01/10/2020 |
| AURA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 07/07/2026 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Directeur Général | - |
Anciens postes connus de Jeremy Bender
| Sociétés | Poste | Fin |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Directeur Général | 23/04/2026 |
| FUSN PHAR | Directeur/Membre du Conseil | 04/06/2024 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2020 |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Directeur des opérations | 01/03/2018 |
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01/07/2015 |
Formation de Jeremy Bender
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Choisissez Zonebourse 
